title: Cross-site Scripting in DEXMA DEXGate
description:
The affected product is vulnerable to a cross-site scripting vulnerability, which could allow an attacker to access the web application to introduce arbitrary Java Script by injecting an XSS payload into the 'hostname' parameter of the vulnerable software.
problem types: CWE-79 Improper Neutralization of Input During Web Page Generation ('Cross-site Scripting')
affected:
{
defaultStatus: unaffected
product: DexGate
vendor: DEXMA
versions:
status: affected, version: 20130114
}
metrics:
cvssV3_1: [
attackComplexity: LOW
attackVector: NETWORK
availabilityImpact: NONE
baseScore: 5.4
baseSeverity: MEDIUM
confidentialityImpact: LOW
integrityImpact: LOW
privilegesRequired: LOW
scope: UNCHANGED
userInteraction: NONE
vectorString: CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:L/I:L/A:N
version: 3.1
]
format: CVSS
scenarios: GENERAL